Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Safiglipron

A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects

Shandong Suncadia Medicine Co · Phase 1/2 · Completed · Enrollment 74

NCT06621316

ArmPopulationDoseWeeksEstimandWeight change
Treatment group AObesity or overweightn/rn/rn/rn/r
Treatment group BObesity or overweightn/rn/rn/rn/r
Treatment group CObesity or overweightn/rn/rn/rn/r
Treatment group DObesity or overweightn/rn/rn/rn/r
Treatment group EObesity or overweightn/rn/rn/rn/r
Treatment group FObesity or overweightn/rn/rn/rn/r
Treatment group GObesity or overweightn/rn/rn/rn/r
Treatment group HObesity or overweightn/rn/rn/rn/r
Treatment group IObesity or overweightn/rn/rn/rn/r
Treatment group JObesity or overweightn/rn/rn/rn/r
Treatment group KObesity or overweightn/rn/rn/rn/r
Treatment group LObesity or overweightn/rn/rn/rn/r